| 2026-03-25 | -34.7% | legal | PR Newswire | IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates |
| 2026-03-25 | -34.7% | news | Stock Titan | IceCure Medical (ICCM) VP details RSUs and stock option grants - Stock Titan |
| 2026-03-25 | -34.7% | news | Stock Titan | IceCure Medical (ICCM) VP discloses shares, RSUs and option grants - Stock Titan |
| 2026-03-25 | -34.7% | news | Stock Titan | [Form 3] IceCure Medical Ltd. Initial Statement of Beneficial Ownership - Stock Titan |
| 2026-03-25 | -34.7% | news | Stock Titan | IceCure Medical (NASDAQ: ICCM) director Chan Vincent Chun Hung files Form 3 - Stock Titan |
| 2026-03-25 | -34.7% | news | Stock Titan | IceCure Medical (ICCM) VP Naum Muchnik details insider share and option holdings - Stock Titan |
| 2026-03-25 | -34.7% | news | Stock Titan | IceCure Medical (ICCM) VP details share, option and RSU holdings - Stock Titan |
| 2026-03-25 | -34.7% | executive | Stock Titan | IceCure Medical (ICCM) CEO details share, RSU and option stakes - Stock Titan |
| 2026-03-25 | -34.7% | news | Stock Titan | IceCure Medical (Nasdaq: ICCM) unveils 5-year kidney cancer data - Stock Titan |
| 2026-03-26 | -32.8% | news | PR Newswire | IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement |
| 2026-03-26 | -32.8% | news | Seeking Alpha | IceCure prices $4M direct offering, concurrent private placement |
| 2026-03-26 | -32.8% | news | PR Newswire | IceCure Announces Pricing of $4.0 Million Registered Direct Offering and Concurrent Private Placement - PR Newswire |
| 2026-03-28 | -24.7% | legal | Stock Titan | ICCM SEC Filings - Icecure Medical Ltd. 10-K, 10-Q, 8-K Forms - Stock Titan |
| 2024-11-08 | -18.2% | legal | Seeking Alpha | IceCure gets favorable FDA AdCom vote for ProSense System |
| 2026-04-22 | -17.2% | news | Stock Titan | Reverse split plan at IceCure Medical (NASDAQ: ICCM) up to 30:1 - Stock Titan |
| 2024-08-20 | +16.7% | earnings | Seeking Alpha | IceCure Medical Ltd (ICCM) Q2 2024 Earnings Call Transcript |
| 2024-08-20 | +16.7% | earnings | Seeking Alpha | IceCure Medical GAAP EPS of -$0.14 misses by $0.07, revenue of $1.75M beats by $0.82M |
| 2026-03-17 | -16.7% | earnings | Motley Fool | IceCure Medical (ICCM) Q4 2025 Earnings Transcript |
| 2026-03-17 | -16.7% | earnings | Moby | IceCure Medical Ltd Q4 2025 Earnings Call Summary |
| 2026-03-17 | -16.7% | news | PR Newswire | IceCure Reports 2025 Full Year Financial & Operational Results |
| 2026-03-17 | -16.7% | earnings | Seeking Alpha | IceCure Medical Ltd (ICCM) Q4 2025 Earnings Call Transcript |
| 2026-03-17 | -16.7% | earnings | Seeking Alpha | IceCure Medical GAAP EPS of -$0.24, revenue of $3.38M |
| 2026-03-17 | -16.7% | news | Stock Titan | IceCure's breast tumor freezing tech sets sales record, eyes 7,130 patients - Stock Titan |
| 2026-03-17 | -16.7% | legal | TipRanks | IceCure Medical Posts Record 2025 Sales as ProSense Cryoablation Adoption Accelerates Post-FDA Clearance - TipRanks |
| 2025-03-20 | -15.0% | legal | Seeking Alpha | IceCure tumbles after updating plans to seek FDA nod for ProSense |
| 2025-08-28 | +13.9% | news | StocksToTrade | IceCure Medical’s Surprising Stock Movement - StocksToTrade |
| 2026-03-11 | +13.7% | legal | PR Newswire | U.S. FDA Approves IceCure's Post-Marketing "ChoICE" Study for ProSense® Cryoablation in the Local Treatment of Low-Risk Breast Cancer |
| 2021-09-05 | +12.9% | earnings | MarketBeat | IceCure Medical (ICCM) Stock Price, News & Analysis - MarketBeat |
| 2025-08-08 | -11.4% | earnings | Yahoo Finance | When Will IceCure Medical Ltd (NASDAQ:ICCM) Turn A Profit? - Yahoo Finance |
| 2026-04-06 | +9.5% | news | Cổng thông tin điện tử tỉnh Tây Ninh | Is IceCure Medical (ICCM) Stock Ready to Drop | Price at $0.32, Up 6.00% - Global Trading Community - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2025-11-19 | -9.1% | earnings | Seeking Alpha | IceCure Medical Ltd (ICCM) Q3 2025 Earnings Call Transcript |
| 2025-11-19 | -9.1% | news | Seeking Alpha | IceCure Medical reports nine months ended results |
| 2025-05-28 | -8.7% | expansion | Seeking Alpha | IceCure Medical outlines post-market study plan for ProSense amid FDA engagement and prepares for US commercial launch |
| 2025-05-28 | -8.7% | earnings | Seeking Alpha | IceCure Medical Ltd (ICCM) Q1 2025 Earnings Call Transcript |
| 2025-05-28 | -8.7% | earnings | Seeking Alpha | IceCure Medical GAAP EPS of -$0.06 beats by $0.02, revenue of $0.73M misses by $0.02M |
| 2023-04-28 | -8.6% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for IceCure Medical (ICCM) - Zacks Investment Research |
| 2024-10-15 | -8.1% | news | Seeking Alpha | IceCure Medical files to sell ordinary shares and warrants |
| 2026-03-24 | -8.1% | executive | PR Newswire | IceCure Appoints Meir Peleg as Chief Financial Officer |
| 2026-03-24 | -8.1% | executive | Seeking Alpha | IceCure appoints Meir Peleg as CFO |
| 2026-03-24 | -8.1% | executive | PR Newswire | IceCure Appoints Meir Peleg as Chief Financial Officer - PR Newswire |
| 2024-07-19 | -7.4% | news | Seeking Alpha | IceCure Medical receives non-compliance notice for continued listing from Nasdaq |
| 2026-01-12 | -7.3% | news | Stock Titan | A frozen alternative to breast surgery gains U.S. authorization - Stock Titan |
| 2025-08-14 | +7.1% | earnings | Yahoo Finance | Icecure Medical Ltd (ICCM) (H1 2025) Earnings Call Highlights: Navigating Challenges and ... - Yahoo Finance |
| 2025-08-14 | +7.1% | executive | simplywall.st | Shareholders May Find It Hard To Justify Increasing IceCure Medical Ltd's (NASDAQ:ICCM) CEO Compensation For Now - simplywall.st |
| 2024-11-26 | +6.9% | earnings | Seeking Alpha | IceCure Medical Ltd (ICCM) Q3 2024 Earnings Call Transcript |
| 2024-11-26 | +6.9% | earnings | Seeking Alpha | IceCure Medical GAAP EPS of $0.22 , revenue of $2.41M |
| 2024-11-26 | +6.9% | news | Seeking Alpha | IceCure Medical reports 36% sales growth in first nine months of 2024 |
| 2023-10-28 | -6.7% | analyst | TradingView | ICCM Forecast — Price Target — Prediction for 2027 - TradingView |
| 2026-03-19 | +6.6% | earnings | Insider Monkey | IceCure Medical Ltd (NASDAQ:ICCM) Q4 2025 Earnings Call Transcript - Insider Monkey |
| 2026-03-02 | +6.5% | news | Stock Titan | Freezing benign breast tumors shrank them 93% in new IceCure study - Stock Titan |
| 2025-01-06 | +5.2% | news | Seeking Alpha | IceCure Medical regains compliance with Nasdaq |
| 2026-03-16 | -4.9% | earnings | GuruFocus.com | What To Expect From Icecure Medical Ltd (ICCM) Q4 2025 Earnings |
| 2026-03-15 | +4.8% | news | Seeking Alpha | Quant snapshot: Micron, Babcock & Wilcox lead strong buys as Fold Holdings, Alvotech lag |
| 2025-10-13 | -4.4% | news | simplywall.st | Investors push IceCure Medical (NASDAQ:ICCM) 13% lower this week, company's increasing losses might be to blame - simplywall.st |
| 2021-08-28 | -3.9% | news | Zacks Investment Research | Should I buy IceCure Medical (ICCM) - Zacks Investment Research |
| 2021-08-28 | -3.9% | earnings | Zacks Investment Research | What date does IceCure Medical's (ICCM) report Earnings - Earnings Calendar & Announcement - Zacks Investment Research |
| 2025-10-06 | +3.7% | news | Seeking Alpha | IceCure Medical Ltd (ICCM) U.S. Food And Drug Administration's Marketing Authorization For ProSense Cryoablation Call Transcript |
| 2023-08-09 | -3.4% | news | CoinCodex | IceCure Medical Ltd (ICCM) Dividend History, Date, and Yield - CoinCodex |
| 2026-04-12 | +3.4% | legal | Stock Titan | [EFFECT] IceCure Medical Ltd. SEC Filing - Stock Titan |
| 2026-03-09 | -3.1% | news | Stock Titan | New breast surgery guide opens nonsurgical freezing option to 200,000 U.S. women - Stock Titan |
| 2026-01-08 | +2.8% | earnings | simplywall.st | When Can We Expect A Profit From IceCure Medical Ltd (NASDAQ:ICCM)? - simplywall.st |
| 2025-09-04 | -2.4% | legal | Seeking Alpha | IceCure Medical files $100M mixed securities shelf |
| 2025-08-13 | +2.3% | earnings | Seeking Alpha | IceCure Medical Ltd (ICCM) Q2 2025 Earnings Call Transcript |
| 2025-08-13 | +2.3% | earnings | Seeking Alpha | IceCure Medical GAAP EPS of $0.12, revenue of $1.25M |
| 2025-09-18 | +2.3% | news | Seeking Alpha | IceCure receives U.S. patent allowance for next-gen XSense cryoprobes; stock climbs |
| 2022-03-09 | -2.2% | news | ChartMill | ICCM Stock Price, Quote & Chart | ICECURE MEDICAL LTD (NASDAQ:ICCM) - ChartMill |
| 2026-02-09 | +1.8% | executive | Seeking Alpha | IceCure CFO Ronen Tsimerman to depart |
| 2026-02-09 | +1.8% | executive | Stock Titan | IceCure CFO who helped Nasdaq listing is stepping down - Stock Titan |
| 2024-05-11 | +1.7% | earnings | MarketBeat | IceCure Medical (ICCM) Stock Forecast and Price Target 2026 - MarketBeat |
| 2026-04-21 | -1.7% | earnings | PR Newswire | IceCure Participates in Society of Breast Imaging Symposium 2026 as U.S. ProSense® Revenue Increases by 30%+ in First Quarter of 2026 Compared to First Quarter of 2025 |
| 2026-04-21 | -1.7% | legal | Stock Titan | [6-K] IceCure Medical Ltd. Current Report (Foreign Issuer) | ICCM SEC Filing - Form 6-K - Stock Titan |
| 2025-05-29 | +1.7% | earnings | Seeking Alpha | IceCure Medical GAAP EPS of -$0.06 beats by $0.01, revenue of $0.73M misses by $0.25M |
| 2023-12-19 | -1.1% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2025-10-07 | -1.1% | analyst | Investing.com | IceCure Medical stock price target raised to $2.50 from $2.00 at H.C. Wainwright - Investing.com |
| 2024-09-12 | -0.9% | legal | Seeking Alpha | FDA AdComm to discuss IceCure's ProSense on Nov. 7 |
| 2025-11-18 | -0.8% | earnings | Yahoo Finance | Icecure Medical Ltd (ICCM) Q3 2025 Earnings Report Preview: What To Expect - Yahoo Finance |
| 2025-11-14 | +0.8% | news | PR Newswire | IceCure Medical Announces Receipt of Nasdaq Minimum Bid Price Notification - PR Newswire |
| 2025-10-03 | +0.7% | legal | Investing.com | Icecure Medical stock surges after FDA approves breast cancer treatment - Investing.com |
| 2026-03-21 | +0.5% | earnings | GuruFocus.com | Icecure Medical Ltd (ICCM) Q4 2025 Earnings Call Highlights: Record Sales and Strategic U.S. ... |
| 2025-03-27 | -0.4% | earnings | Seeking Alpha | IceCure Medical Ltd (ICCM) Q4 2024 Earnings Call Transcript |
| 2025-03-27 | -0.4% | earnings | Seeking Alpha | IceCure Medical GAAP EPS of -$0.30 misses by $0.02, revenue of $3.29M misses by $0.2M |
| 2026-04-16 | -0.3% | news | Cổng thông tin điện tử tỉnh Tây Ninh | IceCure Medical (ICCM) Stock: This Year (Technical Strength) 2026-04-16 - Community Breakout Alerts - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2026-04-03 | +0.2% | news | Cổng thông tin điện tử tỉnh Lào Cai | ICCM Stock Analysis: IceCure Medical Ltd. Ordinary Shares $0.3 mild dip outlook - Cổng thông tin điện tử tỉnh Lào Cai |
| 2022-03-10 | +0.1% | news | ChartMill | ICCM Technical Analysis | Trend, Signals & Chart Patterns | ICECURE MEDICAL LTD (NASDAQ:ICCM) - ChartMill |
| 2026-01-15 | -0.0% | earnings | Yahoo Finance | When Will IceCure Medical Ltd (NASDAQ:ICCM) Turn A Profit? - Yahoo Finance |
| 2021-08-26 | — | news | TradingView | ICCM Stock Price and Chart — NASDAQ:ICCM - TradingView |